Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,200
-60 (-0.45%)
Last updated: Jun 27, 2025

Daewon Pharmaceutical Market Cap

Daewon Pharmaceutical has a market cap or net worth of 283.78 billion as of June 27, 2025. Its market cap has decreased by -7.79% in one year.

Market Cap
283.78B
Enterprise Value
417.26B
Revenue
597.69B
Ranking
n/a
PE Ratio
24.66
Stock Price
13,200.00

Market Cap Chart

Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 283.78B, an increase of 1,471.32%. That is a compound annual growth rate of 11.98%.

History

DateMarket Cap% Change
Jun 27, 2025283.78B-7.09%
Dec 30, 2024305.43B-7.98%
Dec 28, 2023331.93B-15.58%
Dec 29, 2022393.20B14.64%
Dec 30, 2021343.00B-9.91%
Dec 30, 2020380.71B13.65%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 70.89T
Celltrion 35.32T
ALTEOGEN 20.33T
Yuhan 7,706.69B
SK Biopharmaceuticals 7,150.00B
HLB Co., Ltd. 6,270.01B
PharmaResearch 5,044.17B
Peptron 4,775.96B
Market Cap Rankings